Follow the people · Insider
Sherry Korczynski
Sherry Korczynski files insider transactions with the SEC as a chief commercial officer of Aquestive Therapeutics. We hold 2 disclosed purchases and sales filed since 11 June 2024, 1 of them in the last 90 days.
- Files forAQST
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure11 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 7 June 2024 — 9 September 2026Chief Commercial Officer · Aquestive Therapeutics 18 Form 4 lines · source: SEC Form 4
Every transaction
18 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing| 9 Sep 2026 | 11 Sep 2026SEC Form 4 | 2 d | exercised options overnot a trade | Aquestive Therapeutics | 8,750 shares | down −7.2% | up +0.0% |
| 9 Sep 2026 | 11 Sep 2026SEC Form 4 | 2 d | sold on the open market | Aquestive Therapeutics | 8,750 shares | down −7.2% | up +0.0% |
| 9 Sep 2026 | 11 Sep 2026SEC Form 4 | 2 d | exercised options overnot a trade | Aquestive Therapeuticsderivative | 8,750 shares | down −7.2% | up +0.0% |
| 14 Aug 2026 | 17 Aug 2026SEC Form 4 | 3 d | had shares withheld for taxnot a trade | Aquestive Therapeutics | 2,714 shares | up +12.5% | up +11.4% |
| 8 Jun 2026 | 9 Jun 2026SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Aquestive Therapeutics | 2,714 shares | up +22.3% | up +19.8% |
| 10 Mar 2026 | 11 Mar 2026SEC Form 4 | 1 d | sold on the open market | Aquestive Therapeutics | 15,741 shares | up +13.8% | up +11.9% |
| 10 Mar 2026 | 11 Mar 2026SEC Form 4 | 1 d | sold on the open market | Aquestive Therapeutics | 15,741 shares | up +13.8% | up +11.9% |
| 9 Mar 2026 | 11 Mar 2026SEC Form 4 | 2 d | was grantednot a trade | Aquestive Therapeutics | 75,000 shares | up +11.4% | up +11.9% |
| 9 Mar 2026 | 11 Mar 2026SEC Form 4 | 2 d | was grantednot a trade | Aquestive Therapeuticsderivative | 42,500 shares | up +11.4% | up +11.9% |
| 9 Mar 2026 | 11 Mar 2026SEC Form 4 | 2 d | was grantednot a trade | Aquestive Therapeuticsderivative | 42,500 shares | up +11.4% | up +11.9% |
| 9 Mar 2026 | 11 Mar 2026SEC Form 4 | 2 d | was grantednot a trade | Aquestive Therapeutics | 75,000 shares | up +11.4% | up +11.9% |
| 14 Aug 2025 | 15 Aug 2025SEC Form 4 | 1 d | was grantednot a trade | Aquestive Therapeutics | 25,000 shares | up +16.3% | up +16.3% |
| 9 Jun 2025 | 10 Jun 2025SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Aquestive Therapeutics | 2,714 shares | up +35.0% | up +33.5% |
| 7 Mar 2025 | 13 Apr 2026SEC Form 4 | 402 d | was grantednot a trade | Aquestive Therapeuticsderivative | 67,500 shares | up +80.4% | up +14.1% |
| 7 Mar 2025 | 11 Mar 2025SEC Form 4 | 4 d | was grantednot a trade | Aquestive Therapeuticsderivative | 35,000 shares | up +80.4% | up +81.1% |
| 7 Mar 2025 | 11 Mar 2025SEC Form 4 | 4 d | was grantednot a trade | Aquestive Therapeutics | 90,000 shares | up +80.4% | up +81.1% |
| 7 Mar 2025 | 11 Mar 2025SEC Form 4 | 4 d | had shares withheld for taxnot a trade | Aquestive Therapeutics | 5,428 shares | up +80.4% | up +81.1% |
| 7 Jun 2024 | 11 Jun 2024SEC Form 4 | 4 d | was grantednot a trade | Aquestive Therapeutics | 25,000 shares | up +73.8% | up +70.1% |
Both percentages are the stock’s move, not Sherry Korczynski’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 18 of the 18 rows shown carry a percentage; the rest are dashes with the reason on the row.
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.
Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.